264 articles
As of June 11, 2019, Merck's KEYTRUDA is now FDA approved for first-line treatment of patients with metastatic or with unresectable, recurrent head and ...
Gerard Clum, D.C., Board Member of the Foundation for Chiropractic Progress, addresses the issues surrounding neck manipulation and strokes.
Mike Davis, Head of Neurology for UCB, a global biopharmaceutical company in the U.S., discusses the recent FDA approval of NAYZILAM® (midazolam) for t...
John Incledon, President of Hisamitsu America (the makers of Salonpas patches), discusses the Centers for Disease Control's recent recommendation for ph...
Yutaka Niihara, CEO of Emmaus Life Sciences, discusses Sickle Cell Disease in underserved minority populations and his passion for finding a treatment.
Eric Snyder from Geneticure discusses their recently presented data on a study utilizing their algorithm which can predict which hypertension drug would...
Pamela Jones, MD, from Massachusetts General Hospital and a presenter at the 2019 American Association of Neurological Surgeons (AANS) Scientific Meetin...
In this health supplier segment, pediatric emergency physician and pain specialist, Dr. Learn more on Health Professional Radio.
David Arthur, CEO of Salarius Pharmaceuticals, discusses the enrollment in a Phase 1 trial for their lead program which is for the treatment of Ewing Sa...
CJ Barnum, Ph.D., Director of Neuroscience for INmune Bio discusses the award of a $1 million dollar grant from the Alzheimer's Association to begin a c...